February 27, 2022 3:38 AM
Indications for 2022
BY HEALTH CAPITAL CONSULTANTS, LLC
***
2021 M&A in Review: Indications for 2022
After an understandable slowdown in 2020, due to the onset of the COVID-19 pandemic, merger & acquisition (M&A) activity in the healthcare industry accelerated in 2021, and the industry is expected to continue the high number of deals and high deal volume in 2022.
***

***
This Health Capital Topics article will review the U.S. healthcare industry’s M&A activity in 2021, and discuss what these trends may mean for 2022. (Read more…)
***
CITE: https://www.r2library.com/Resource/Title/0826102549
COMMENTS APPRECIATED
Thank You
Subscribe to the Medical Executive-Post
***
***
***
Posted by Dr. David Edward Marcinko MBA MEd CMP™
Categories: "Ask-an-Advisor", Accounting, Ethics, Experts Invited, Health Economics, Health Insurance, Health Law & Policy, Healthcare Finance, iMBA, Inc., Managed Care
Tags: Covid-19, Health Capital Consultants LLC, healthcare mergers acquisitions, HEALTHCARE: 2021 M&A in Review, M&As
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.